在多发性骨髓瘤中最小残留疾病
Nour Moukalled1, Florent Malard2, Ali Bazarbachi1
1Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
概括
在多发性骨髓瘤中,最小残留疾病 (MRD) 的检测至关重要. 实现MRD负面性与更好的生存率相关,指导患者未来的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 最小残留疾病 (MRD) 是多发性骨髓瘤的关键预后因素,影响治疗决策和患者的治疗结果.
- 尽管有先进的治疗方法,但完全根除恶性血细胞仍然很困难.
- 敏感的检测方法对于识别残留疾病至关重要.
研究的目的:
- 要突出MRD在多发性骨髓瘤的预后意义.
- 讨论MRD阴性在预测患者存活率和指导治疗调整中的作用.
- 为了应对MRD监测的挑战和未来方向.
主要方法:
- 使用敏感技术,如下一代流细胞计 (NGF) 和下一代测序 (NGS) 来检测MRD.
- 分析MRD状态和临床结果之间的关联,如无进展生存率 (PFS) 和总生存率 (OS).
- 审查多发性骨髓瘤当前和新兴的治疗策略.
主要成果:
- 在多发性骨髓瘤患者中,MRD消极性与改善的PFS和OS密切相关.
- 持续的MRD消极性预测了长时间的存活率,并支持治疗降级.
- MRD 状态可以指导高风险个体的治疗升级.
结论:
- MRD是预测结局和个性化治疗多发性骨髓瘤的重要生物标志物.
- 标准化MRD测试和可访问性仍然是关键的挑战.
- 未来的研究应该专注于改进MRD引导的疗法,并探索新的检测方法,如液体活检.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.2K
07:53Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022
4.2K
相关概念视频
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
